BCR-ABL SIGNALING A new STATus in CML

被引：0
作者：
Fabbro, Doriano [1 ]
机构：
[1] Novartis Inst Biomed Res, Basel, Switzerland
来源：
NATURE CHEMICAL BIOLOGY | 2012年 / 8卷 / 03期
关键词：
CHRONIC MYELOID-LEUKEMIA; BCR/ABL;
D O I：
10.1038/nchembio.900
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [21] IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation
    Massimino, Michele
    Consoli, Maria Letizia
    Mesuraca, Maria
    Stagno, Fabio
    Tirro, Elena
    Stella, Stefania
    Pennisi, Maria Stella
    Romano, Chiara
    Buffa, Pietro
    Bond, Heather M.
    Morrone, Giovanni
    Sciacca, Laura
    Di Raimondo, Francesco
    Manzella, Livia
    Vigneri, Paolo
    CARCINOGENESIS, 2014, 35 (05) : 1132 - 1143
  • [22] Multidomain Targeting of Bcr-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML
    Miller, Geoffrey D.
    Woessner, David W.
    Sirch, Monika J.
    Lim, Carol S.
    MOLECULAR PHARMACEUTICS, 2013, 10 (09) : 3475 - 3483
  • [23] New Insights Into Small-Molecule Inhibitors of Bcr-Abl
    Schenone, S.
    Bruno, O.
    Radi, M.
    Botta, M.
    MEDICINAL RESEARCH REVIEWS, 2011, 31 (01) : 1 - 41
  • [24] Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML
    Bakshi, Sonal R.
    Patel, Beena P.
    Brahmbhatt, Manisha M.
    Trivedi, Pina J.
    Gajjar, Sarju B.
    Iyer, Ramesh R.
    Parikh, Esha H.
    Shukla, Shilin N.
    Shah, Pankaj M.
    CANCER GENETICS AND CYTOGENETICS, 2009, 189 (02) : 142 - 143
  • [25] Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML
    Agarwal, Anupriya
    Fleischman, Angela G.
    Petersen, Curtis L.
    MacKenzie, Ryan
    Luty, Samuel
    Loriaux, Marc
    Druker, Brian J.
    Woltjer, Randall L.
    Deininger, Michael W.
    BLOOD, 2012, 120 (13) : 2658 - 2668
  • [26] ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance
    Ferreira, A. F.
    Moura, L. G.
    Tojal, I.
    Ambrosio, L.
    Pinto-Simoes, B.
    Hamerschlak, N.
    Calin, G. A.
    Ivan, C.
    Covas, D. T.
    Kashima, S.
    Castro, F. A.
    BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (1-2) : 47 - 55
  • [27] Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
    Malik, Vidhi
    Radhakrishnan, Navaneethan
    Kaul, Sunil C.
    Wadhwa, Renu
    Sundar, Durai
    BIOMOLECULES, 2022, 12 (02)
  • [28] Bcr-Abl induces autocrine IGF-1 signaling
    A Lakshmikuttyamma
    E Pastural
    N Takahashi
    K Sawada
    D P Sheridan
    J F DeCoteau
    C R Geyer
    Oncogene, 2008, 27 : 3831 - 3844
  • [29] Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia
    Samanta, A.
    Perazzona, B.
    Chakraborty, S.
    Sun, X.
    Modi, H.
    Bhatia, R.
    Priebe, W.
    Arlinghaus, R.
    LEUKEMIA, 2011, 25 (03) : 463 - 472
  • [30] Bcr-Abl induces autocrine IGF-1 signaling
    Lakshmikuttyamma, A.
    Pastural, E.
    Takahashi, N.
    Sawada, K.
    Sheridan, D. P.
    DeCoteau, J. F.
    Geyer, C. R.
    ONCOGENE, 2008, 27 (27) : 3831 - 3844
12345